This is a preview of subscription content, log in via an institution to check access.
References
Bjordal, J., Klovning, A., Ljunggren, A., & Slordal, L. (2007). Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. European Journal of Pain, 11(2), 125–138.
Chan, C. C., Reid, C. M., Aw, T. J., Liew, D., Haas, S. J., & Krum, H. (2009). Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. Journal of Hypertension, 27(12), 2332–2341.
Day, R.O., & Graham, G.G. (2013). Therapeutics. Non-steroidal anti-inflammatory drugs (NSAIDs). British Medical Journal, 346(f3195).
El Miedany, Y., Youssef, S., Ahmed, I., & El Gaafary, M. (2008). Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. Annals of Allergy, Asthma & Immunology, 97(1), 105–109. 2006., 97(1), 105–109.
Fortun, P. J., & Hawkey, C. J. (2005). Nonsteroidal antiinflammatory drugs and the small intestne. Current Opinion in Gastroenterology, 21, 169–175.
Hansten, P. D., & Horn, J. T. (2007–2012). Drug interactions: Analysis and management, Wolters Kluwer, Alphen aan den Rijn, Netherlands.
Hao, C. M., & Breyer, M. D. (2008). Physiological regulation of prostaglandins in the kidney. Annual Review of Physiology, 70, 357–377.
Hay, E., Derazon, H., Bukish, N., Katz, L., Kruglyakov, I., & Armoni, M. (2002). Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet. Journal of Emergency Medicine, 22(4), 349–352.
Hunt, R. H., Lanas, A., Stichtenoth, D. O., & Scarpignato, C. (2009). Myths and facts in the use of anti-inflammatory drugs. Annals of Medicine, 41(6), 423–437.
Kraus, S., Naumov, I., & Arber, N. (2013). COX-2 active agents in the chemoprevention of colorectal cancer. Recent Results in Cancer Research, 191, 95–103.
Latimer, N., Lord, J., Grant, R., O’Mahony, R., Dickson, J., & Conaghan, P. (2009). Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. British Medical Journal, 339, b2538.
McCormack, P. L. (2011). Celecoxib: A review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Drugs, 71(18), 2457–2489.
Moreira, L., & Castells, A. (2011). Cyclooxygenase as a target for colorectal cancer chemoprevention. Current Drug Targets, 12(13), 1888–1894.
Rios, A., Vargas-Robles, H., Gamez-Mendez, A. M., & Escalante, B. (2012). Cyclooxygenase-2 and kidney failure. Prostaglandins & Other Lipid Mediators, 98(3–4), 86–90.
Roddy, E., Zhang, W., & Doherty, M. (2005). Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review. Annals of the Rheumatic Diseases, 64(4), 544–548.
Sacchetti, A. (2013). Cancer cell killing by Celecoxib: Reality or just in vitro precipitation-related artifact? Journal of Cellular Biochemistry, 114(6), 1434–1444.
Sanchez-Borges, M., Caballero-Fonseca, F., & Capriles-Hulett, A. (2005). Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Annals of Allergy, Asthma & Immunology, 95(2), 154–158.
Shi, S., & Klotz, U. (2008). Clinical use and pharmacological properties of selective COX-2 inhibitors. European Journal of Clinical Pharmacology, 64(3), 233–252.
Smith, W. L., DeWitt, D. L., & Gravito, R. M. (2000). Cyclooxygenases: Structures, cellular, and molecular biology. Annual Review of Biochemistry, 69, 145–182.
Stevenson, D. D. (2004). Aspirin and NSAID sensitivity. Immunology & Allergy Clinics of North America, 24(3), 491–505.
Strand, V., Simon, L. S., Dougados, M., Sands, G. H., Bhadra, P., Breazna, A., et al. (2011). Treatment of osteoarthritis with continuous versus intermittent celecoxib. Journal of Rheumatology, 38(12), 2625–2634.
Wang, D., & DuBois, R. N. (2013). The role of anti-inflammatory drugs in colorectal cancer. Annual Review of Medicine, 64, 131–144.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Basel
About this entry
Cite this entry
Graham, G.G., Day, R.O. (2016). Coxibs. In: Parnham, M. (eds) Compendium of Inflammatory Diseases. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-0620-6_22-2
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0620-6_22-2
Received:
Accepted:
Published:
Publisher Name: Birkhäuser, Basel
Online ISBN: 978-3-0348-0620-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences